Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Quality of Life Score as a Predictor of Death in Dogs with Degenerative Mitral Valve Disease.

Strunz CMC, Marcondes-Santos M, Takada JY, Fragata FS, Mansur AP.

Arq Bras Cardiol. 2017 Apr;108(4):347-353. doi: 10.5935/abc.20170032. Epub 2017 Mar 30. English, Portuguese.

2.
3.

Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients.

Ozcan N, Ozcan A, Kaymak C, Basar H, Kotanoglu M, Kose B.

Arch Med Sci. 2017 Mar 1;13(2):418-425. doi: 10.5114/aoms.2015.54196. Epub 2017 Feb 15.

4.

Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart Failure.

Fukuda H, Suwa H, Nakano A, Sakamoto M, Imazu M, Hasegawa T, Takahama H, Amaki M, Kanzaki H, Anzai T, Mochizuki N, Ishii A, Asanuma H, Asakura M, Washio T, Kitakaze M.

Sci Rep. 2016 Nov 15;6:37073. doi: 10.1038/srep37073.

5.

Cocoa flavanols reduce N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure.

De Palma R, Sotto I, Wood EG, Khan NQ, Butler J, Johnston A, Rothman MT, Corder R.

ESC Heart Fail. 2016 Jun;3(2):97-106. Epub 2015 Dec 8.

6.

Predictors of Mortality in Paediatric Myocarditis.

Abrar S, Ansari MJ, Mittal M, Kushwaha KP.

J Clin Diagn Res. 2016 Jun;10(6):SC12-6. doi: 10.7860/JCDR/2016/19856.7967. Epub 2016 Jun 1.

7.

N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.

Huang YT, Tseng YT, Chu TW, Chen J, Lai MY, Tang WR, Shiao CC.

Sci Rep. 2016 Jul 14;6:29590. doi: 10.1038/srep29590.

9.

Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure.

Arimura T, Miura S, Morito N, Shiga Y, Kitajima K, Morii J, Iwata A, Fujimi K, Yahiro E, Saku K.

J Clin Med Res. 2016 Feb;8(2):97-104. doi: 10.14740/jocmr2402w. Epub 2015 Dec 28.

10.

Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.

Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR.

JACC Heart Fail. 2015 Dec;3(12):977-89. doi: 10.1016/j.jchf.2015.07.014. Review.

11.

Brain Natriuretic Peptide as the long-term cause of mortality in patients with cardiovascular disease: a retrospective cohort study.

Zhang C, Huang D, Shen D, Zhang L, Wang Y, Sun H, Ma Y.

Int J Clin Exp Med. 2015 Sep 15;8(9):16364-8. eCollection 2015.

12.

INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist.

Ramos HR, Birkenfeld AL, de Bold AJ.

Endocr Connect. 2015 Sep;4(3):R25-36. doi: 10.1530/EC-15-0018. Review.

13.

Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.

Liu Y, He YT, Tan N, Chen JY, Liu YH, Yang DH, Huang SJ, Ye P, Li HL, Ran P, Duan CY, Chen SQ, Zhou YL, Chen PY.

J Am Heart Assoc. 2015 Apr 17;4(4). pii: e001410. doi: 10.1161/JAHA.114.001410.

14.

Evaluation of CA125 and NT-proBNP values in patients undergoing transcatheter aortic valve implantation.

Ayhan H, Kasapkara HA, Durmaz T, Keleş T, Sarı C, Baştuğ S, Erdoğan KE, Bayram NA, Bilen E, Akçay M, Bozkurt E.

J Geriatr Cardiol. 2015 Mar;12(2):100-6. doi: 10.11909/j.issn.1671-5411.2015.02.002.

15.

Relationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.

Lu Z, Wang B, Wang Y, Qian X, Zheng W, Wei M.

Biomed Res Int. 2014;2014:106252. doi: 10.1155/2014/106252. Epub 2014 Aug 28.

16.

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure.

Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Leifer ES, Mark DB, Desvigne-Nickens P, Paynter G, Piña IL, Whellan DJ, O'Connor CM.

JACC Heart Fail. 2014 Oct;2(5):457-65. doi: 10.1016/j.jchf.2014.05.007. Epub 2014 Sep 3.

17.

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Madamanchi C, Alhosaini H, Sumida A, Runge MS.

Int J Cardiol. 2014 Oct 20;176(3):611-7. doi: 10.1016/j.ijcard.2014.08.007. Epub 2014 Aug 9. Review.

18.

Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP.

Giannoni A, Baruah R, Leong T, Rehman MB, Pastormerlo LE, Harrell FE, Coats AJ, Francis DP.

PLoS One. 2014 Jan 27;9(1):e81699. doi: 10.1371/journal.pone.0081699. eCollection 2014. Review. Erratum in: PLoS One. 2014 Sep;9(9):e105175.

19.

Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction.

Waldum B, Stubnova V, Westheim AS, Omland T, Grundtvig M, Os I.

Clin Kidney J. 2013 Feb;6(1):55-62. Epub 2012 Dec 21.

20.

Cardiac biomarkers: new tools for heart failure management.

Iqbal N, Wentworth B, Choudhary R, Landa Ade L, Kipper B, Fard A, Maisel AS.

Cardiovasc Diagn Ther. 2012 Jun;2(2):147-64. doi: 10.3978/j.issn.2223-3652.2012.06.03. Review.

Supplemental Content

Support Center